Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,658,321 papers from all fields of science
Search
Sign In
Create Free Account
batracylin
Known as:
8-Aminoisoindolo(1,2-b)quinazolin-12(10H)-one
, 8-aminoisoindolo(1,2-b)quinazolin-12(10H)one
, DANIQUIDONE
A water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
DNA
Narrower (1)
NSC 320846
Broader (1)
Quinazolines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations In Vitro.
J. Covey
,
J. Reid
,
+4 authors
M. Ames
Journal of Drug Metabolism & Toxicology
2016
Corpus ID: 22212949
BACKGROUND Batracylin is a heterocyclic arylamine topoisomerase inhibitor with preclinical anticancer activity. Marked species…
Expand
2014
2014
Palladium-catalyzed synthesis of isoindoloquinazolinones via dicarbonylation of 1,2-dibromoarenes.
Jianbin Chen
,
H. Neumann
,
M. Beller
,
Xiao‐Feng Wu
Organic and biomolecular chemistry
2014
Corpus ID: 820050
A convenient procedure for the carbonylative synthesis of isoindoloquinazolinones has been developed. Using 1,2-dibromobenzenes…
Expand
2007
2007
Batracylin, 8-aminoisoindolo [1,2-b]quinazolin-10(12H)-one (NSC 320846), a dual inhibitor of DNA topoisomerases I and II: molecular mechanisms and γ-H2AX as a biomarker of DNA damage.
V. A. Rao
,
K. Agama
,
S. Holbeck
,
Y. Pommier
2007
Corpus ID: 88355336
A172 Batracylin (8-aminoisoindolo [1,2-b]quinazolin-10(12H)-one; NSC320846) is an investigational clinical anticancer agent…
Expand
2004
2004
Antitumor drug cross-resistance in vivo in a cisplatin-resistant murine P388 leukemia
W. Waud
,
S. Harrison
,
Karen S. Gilbert
,
W. R. Laster
,
D. Griswold
Cancer Chemotherapy and Pharmacology
2004
Corpus ID: 10159177
SummarySince 1978, over 50 clinically useful antitumor drugs or new candidate antitumor agents have been evaluated in vivo…
Expand
2004
2004
Toxicity of the heterocyclic amine batracylin: investigation of rodent N-acetyltransferase activity and potential contribution of cytochrome P450 3A
G. Stevens
,
J. Burkey
,
C. Mcqueen
Cell Biology and Toxicology
2004
Corpus ID: 21993724
The heterocyclic amine, batracylin (BAT), is genotoxic and several lines of evidence suggest that acetylation is one step in the…
Expand
1995
1995
The role of n-acetylation in the genotoxicity of the antitumor agent, batracylin.
G. Stevens
1995
Corpus ID: 108005516
1993
1993
A structure-activity relationship study of batracylin analogues.
Y. Luo
,
Y. Ren
,
+4 authors
C. Cheng
Pharmaceutical Research
1993
Corpus ID: 34374262
A number of isoindolo[1,2-b]quinazolines and some benzo[4,5]isoquinolino[1,2-b]quinazolines as structural modification analogues…
Expand
1989
1989
High-performance liquid chromatographic assay and preclinical pharmacologic studies with the experimental antitumor agent batracylin.
M. Ames
,
D. Mathiesen
Journal of Chromatography A
1989
Corpus ID: 29103296
1988
1988
A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
G. Atassi
,
P. Dumont
,
H. Kabbe
,
O. Yoder
Drugs under experimental and clinical research
1988
Corpus ID: 38090228
The antitumour efficacy of batracylin was investigated in vivo against murine tumours. The drug displayed an original spectrum of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE